Form D — ENDRA Life Sciences Inc.
0001681682-25-000004 · filed Oct 24, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(c)
- Reported offering amount
- $14,402,880
- Reported amount sold
- $14,402,880
- Minimum investment
- $200,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ENDRA Life Sciences Inc.
- CIK
- 1681682
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3600 GREEN COURT
ANN ARBOR, Michigan 48105 - Phone
- 734-335-0468
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alexander Tokman · Executive OfficerAnn Arbor, Michigan Find on LinkedIn ↗
-
Michael Thornton · Executive OfficerAnn Arbor, Michigan Find on LinkedIn ↗
-
Richard Jacroux · Executive OfficerAnn Arbor, Michigan Find on LinkedIn ↗
-
Louis J. Basenese · DirectorAnn Arbor, Michigan Find on LinkedIn ↗
-
Anthony DiGiandomenico · DirectorAnn Arbor, Michigan Find on LinkedIn ↗
-
Michael Harsh · DirectorAnn Arbor, Michigan Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗